| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $173.7M | -14.6% |
| Cost of Revenue | $80.4M | -14.5% |
| Gross Profit | $93.3M | -14.7% |
| R&D Expense | $7.5M | -59.4% |
| SG&A Expense | $87.4M | -15.3% |
| Operating Income | -$11.3M | +49.8% |
| Pre-tax Income | -$11.7M | +57.3% |
| Income Tax | $33K | -17.5% |
| Net Income | -$11.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.5M | -56.7% |
| Accounts Receivable | $3.1M | +608.7% |
| Inventory | $18.4M | -4.8% |
| Current Assets | $34.7M | -22.8% |
| Total Assets | $53.1M | -18.3% |
| Current Liabilities | $27.7M | +2.3% |
| Long-term Debt | $6.7M | -10.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | +28.7% |
| Capital Expenditures | $1.2M | -33.6% |
| Investing Cash Flow | -$4.0M | -146.7% |
| Financing Cash Flow | -$1.6M | +97.4% |
| Free Cash Flow | -$8.1M | +29.4% |
| +57.3% |
| EPS (Basic) | -$0.34 | +55.3% |
| EPS (Diluted) | -$0.34 | +55.3% |
| Total Liabilities |
| $45.3M |
| -7.1% |
| Stockholders' Equity | -$17.0M | -98.8% |